
























参考图片
Western blot analysis of PARP cleavage. Jurkat cells (Human T-cell leukemia; ATCC TIB-152) were induced to undergo CD95 (Fas) mediated apoptosis by treatment with mouse anti-human CD95 antibody (clone DX2) (MN 555670) and Protein G for 4 hr (lane 2) or were untreated (lane 1). Lysates were probed with the purified mouse anti-PARP antibody (clone C2-10) at a dilution of 1:2000. The 116 kDa intact form of PARP is observed in both the untreated and anti-CD95 treated cell lysates. However, the 89 kDa PARP cleavage fragment is seen only in the treated cell lysates.
Western blot analysis of PARP cleavage. Jurkat cells (Human T-cell leukemia; ATCC TIB-152) were induced to undergo CD95 (Fas) mediated apoptosis by treatment with mouse anti-human CD95 antibody (clone DX2) (MN 555670) and Protein G for 4 hr (lane 2) or were untreated (lane 1). Lysates were probed with the purified mouse anti-PARP antibody (clone C2-10) at a dilution of 1:2000. The 116 kDa intact form of PARP is observed in both the untreated and anti-CD95 treated cell lysates. However, the 89 kDa PARP cleavage fragment is seen only in the treated cell lysates.